$WKL (-7.46%) Highlights
🟢 Revenue: -3% reported | +4% constant FX | +5% organic
🟢 Recurring Revenue: +7% organic (85% of total)
🔴 Non-Recurring Revenue: -5% organic
🟢 Cloud Revenue: +14% organic (23% mix)
🟢 Adj. Operating Profit: +11% constant FX
🟡 Free Cash Flow: +15% (timing-driven)
🟢 Net Debt / EBITDA: 1.9x
Operations
🟢 Organic growth stable at +5%
🟢 Strong shift to recurring + cloud mix
🔴 Print impact: -130bps drag
🔴 Weakness in licenses & services
🟢 Solid divisional performance (Health standout)
Strategy
🟢 Cloud transition executing well
🟢 AI integration gaining traction
🟡 Investment weighted to H2
Outlook
🟢 Full-year guidance confirmed
🟡 Growth and margins H2 skewed
🧠 Summary
🟢 Core business intact and consistent
🟢 Recurring & cloud mix improving quality
🟢 AI = tailwind, not disruption
🔴 Weak areas are structural (print, non-recurring)
👉 Market weakness driven by AI fears looks overdone
👉 Fundamentals remain strong → high-quality compounder intact